Melanoma in organ transplant recipients: The old enemy finds a new battleground

Australasian Journal of Dermatology

Volumn 48, Issue 4, 2007, Pages 199-207

  Dinh, Quan Q ^a   Chong, Alvin H ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cutaneous carcinogenesis; Renal transplant recipient; Skin cancer; Transplantation

Indexed keywords

ARTICLE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; INCIDENCE; MELANOCYTIC NEVUS; MELANOMA; METASTASIS; PROGNOSIS; RISK FACTOR; SURVIVAL RATE;

ADULT; CHILD; FEMALE; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; MALE; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEVUS, PIGMENTED; ORGAN TRANSPLANTATION; PROGNOSIS; RISK FACTORS; SKIN NEOPLASMS;

EID: 35448988604     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2007.00387.x     Document Type: Article

References (34)

1. Jensen P, Hansen S, Moller B, Leivestad T, Pfefer P, Geiran O, Fauchald P, Simonsen S. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J. Am. Acad. Dermatol. 1999 40 : 177 86.
2. Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990 49 : 506 9.
3. Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, Mac-Naught A, O'Sullivan B, Siskind V, Van Der Woude FJ, Hardie IR. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996 61 : 715 21.
4. Sheil AG, Disney AP, Mathew TH, Amiss N. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant. Proc. 1993 25 : 1383 4.
5. Vajdic CM, McDonald SP, McCredie MRE, van Leeuwen MT, Stewart JH, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE. Cancer incidence before and after kidney transplantation. JAMA 2006 296 : 2823 31.
6. Webster A, Chapman J. Cancer report. In : McDonald S, Excell L (eds). ANZDATA Registry Report 2005. Adelaide, South Australia : Australia and New Zealand Dialysis and Transplant Registry, 2005 132 9.
7. Sheil AG, Flavel S, Disney AP, Mathew TH, Hall BM. Cancer incidence in renal transplant patients treated with azathioprine or cyclosporine. Transplant. Proc. 1987 19 : 2214 16.
8. Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int. J. Cancer 1995 60 : 183 9.
9. Adami J, Gabel H, Lindelof B, Ekstrom K, Rydh B, Glimelius B, Ekbom A, Adami HO, Granath F. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br. J. Cancer 2003 89 : 1221 7.
10. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br. J. Dermatol. 2000 143 : 513 19.
11. Birkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet 2000 355 : 1886 7.
12. Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh G, Reyes J, Zak M, Rakela J, Irish W, Fung JJ. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998 66 : 1193 200.
13. Le Mire L, Hollowood K, Gray D, Bordea C, Wojnarowska F. Melanomas in renal transplant recipients. Br. J. Dermatol. 2006 154 : 472 7.
14. Moloney FJ, Comber H, O'Lorcain P, O'Kelly P, Conlon PJ, Murphy GM. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br. J. Dermatol. 2006 154 : 498 504.
15. Penn I. De novo malignances in pediatric organ transplant recipients. Pediatr. Transplant. 1998 2 : 56 63.
16. Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996 61 : 274 8.
17. Ceballos PI, Ruiz-Maldonado R, Mihm MC Jr. Melanoma in children. N. Engl. J. Med. 1995 332 : 656 62.
18. Smith CH, McGregor JM, Barker JN, Morris RW, Rigden SP, Macdonald DM. Excess melanocytic nevi in children with renal allografts. J. Am. Acad. Dermatol. 1993 28 : 51 5.
19. Szepietowski J, Wasik F, Szepietowski T, Wlodarczyk M, Sobczak-Radwan K, Czyz W. Excess benign melanocytic naevi in renal transplant recipients. Dermatology 1997 194 : 17 19.
20. Greene MH, Young TI, Clark WH Jr. Malignant melanoma in renal transplant recipients. Lancet 1981 1 : 1196 9.
21. Dantal J, Hourmant M, Cantarovich D, Giral M, Blancho G, Dreno B, Soulilou JP. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998 351 : 623 8.
22. Glover MT, Deeks JJ, Raftery MJ, Cunningham J, Leigh IM. Immunosuppression and risk of nonmelanoma skin cancer in renal transplant recipients. Lancet 1997 349 : 398.
23. Moloney FJ, Kelly PO, Kay EW, Conlon P, Murphy GM. Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma. Dermatol. Surg. 2004 30 : 674 8.
24. Trofe J, Buell J, Hanaway M, First R, Beebe T, Woodle ES. Melanoma in solid organ transplantation: a 25 year experience in 143 patients from the Israel Penn International Transplant Tumor Registry. Am. J. Transplant. 2001 1 : 389. (Abstract 1005.)
25. Leveque L, Dalac S, Dompmartin A, Louvet S, Euvrard S, Catteau B et al. [Melanoma in organ transplant patients.] Ann. Dermatol. Venereol. 2000 127 : 160 5. (Article in French with English abstract.)
26. Bulliard JL, De Weck D, Fisch T, Bordoni A, Levi F. Detailed site distribution of melanoma and sunlight exposure: aetiological patterns from a Swiss series. Ann. Oncol. 2007 18 : 789 94.
27. South Australian Cancer Registry. Epidemiology of Cancer in South Australia. Incidence, Mortality and Survival 1977 to 1996 Incidence and Mortality 1996. Analysed by Type and Geographical Location. Twenty Years of Data. Adelaide : Openbook Publishers 1997.
28. Clark WH, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969 29 : 705 27.
29. Lens MB, Dawes M, Newton-Bishop JA, Goodacre T. Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy. Br. J. Surg. 2002 89 : 1223 7.
30. Puleo CA, Messina JL, Riker AI, Glass LF, Nelson C, Cruse CW, Johnson TM, Sondak VK. Sentinel node biopsy for thin melanomas: which patients should be considered? Cancer Control 2005 12 : 230 5.
31. Stasko T. Conference Report. First Annual Meeting of the International Transplant Skin Cancer Collaborative, March 20, 2003, San Francisco, California, at http://www.medscape.com/viewarticle/452058. (Accessed 9 Oct 2006.)
32. Berg D, Otley CC. Skin cancer in organ transplant recipients. Epidemiology, pathogenesis, and management. J. Am. Acad. Dermatol. 2002 47 : 1 17.
33. International Transplant Skin Cancer Collaborative. Mission Statement, at http://www.itscc.org/. (Accessed 6 Jun 2007.)
34. Skin Care in Organ Transplant Patients Europe Network. Skin Care in Organ Transplant Patients Europe, at http://www.scopnetwork.org/network.html. (Accessed 6 Jun 2007.)